Inactive Instrument

Amoéba Stock Euronext Paris

News in other languages: Amoéba

24/07	Amoéba : Amoéba et Koppert étendent la durée de leur accord de distribution pour la technologie AXPERA et confirment leurs ambitions communes dans les biofongicides innovants
01/07	Amoéba verkrijgt in Frankrijk een vergunning voor het in de handel brengen van zijn biofungicide AXPERA
01/07	Amoéba ottiene l’autorizzazione all'immissione in commercio in Francia per il suo biofungicida AXPERA
01/07	Amoéba obtient l’autorisation de mise sur le marché en France pour son biofongicide AXPERA
01/07	Amoéba obtiene la autorización de comercialización en Francia para su biofungicida AXPERA

More news

Managers and Directors: Amoéba

Manager	Title	Age	Since
Dominique Jean Francois Marie Doucet CEO	Chief Executive Officer	60	14/12/2023
Sandrine Troussieux CTO	Chief Tech/Sci/R&D Officer	-	01/09/2018
Hervé Testeil PRN	Corporate Officer/Principal	-	01/03/2022

Director	Title	Age	Since
Valérie Filiatre BRD	Director/Board Member	-	01/06/2014
Benoît Villers CHM	Chairman	70	14/12/2023
Jean-luc Souche BRD	Director/Board Member	70	25/05/2023

More insiders

Amoéba is a greentech company whose ambition is to become a major player in the treatment of microbiological risk based on the patented use of amoebae in the plant protection and cosmetics sectors. With know-how that is unique in the world and protected by numerous patents, Amoéba is currently the only company capable of exploiting the full potential of the Willaertia amoeba on an industrial scale and cultivating it in sufficient volumes to offer biological solutions that constitute a viable alternative to the chemical products widely used today. Amoéba is currently focusing on the global biocontrol market for plant protection and on the cosmetics market.

Employees

Sector

Agricultural Chemicals

More about the company

The best tools reserved for subscribers to boost the performance of your investments!

Market Cap	46.77M 53.3M 43.56M 40.06M 75.1M 5.09B 76.39M 517M 202M 2.53B 200M 196M 8.72B	P/E 2026 *	-9.05x	P/E 2027 *	67.9x
Enterprise Value	57.92M 66M 53.94M 49.61M 93M 6.31B 94.59M 640M 250M 3.13B 248M 242M 10.8B	EV / Sales 2026 *	11.4x	EV / Sales 2027 *	3.77x
Free-Float	87.09%	Yield 2026 *	-	Yield 2027 *	-

24/07	Amoéba and Koppert Extends Distribution Agreement for Axpera Technology and Reaffirm Their Shared Ambitions in the Field of Innovative Biofungicides	CI
01/07	Amoéba Receives Marketing Authorization For Biofungicide AXPERA In France	CI
01/07	Amoéba gains from marketing authorization in France
30/06	Amoéba Bags Marketing Approval for Biofungicide in France	MT
30/06	Amoéba wins marketing authorization in France
09/06	Amoéba S.A. Obtains 120-Day Emergency Authorization for Use of Biofungicide AXPERA Against Basil Downy Mildew in Italy	CI
09/06	Amoéba secures strategic emergency authorization in Italy
07/05	Amoéba Announces Two New Exceptional Trial Permits for Biocontrol Solution in the Netherlands	CI
29/04	Amoéba Announces Emergency Authorization for Axpera Biocontrol Solution	CI
29/04	Amoéba secures emergency authorization for downy mildew treatment in France
14/04	Amoéba and Koppert Highlight the Potential of Axpera Technology in Brazil for Strategic Crops	CI
26/03	Amoéba Raises EUR7 Million via Private Placement	MT
26/03	Amoëba successfully completes capital increase

24/07	Amoéba : Amoéba and Koppert extend their distribution agreement for AXPERA technology and reaffirm their shared ambitions in the field of innovative biofungicides	AT
01/07	Amoéba has received marketing authorization in France for its biofungicide AXPERA	GL
30/06	Amoéba : Amoéba has received marketing authorization in France for its biofungicide AXPERA	AT
09/06	Amoéba : Amoéba obtains in Italy a 120 day emergency authorization for the use of its biofungicide AXPERA against basil downy mildew	AT
07/05	Amoéba : Two new exceptional trial permits in the Netherlands in 2026 for Amoéba’s biocontrol solution	AT

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
AMOÉBA	-.--%	-11.21%	-	-	52.81M
JIANGSU YANGNONG CHEMICAL CO., LTD.	+0.47%	+0.46%	-19.08%	-21.67%	3.26B
ZHEJIANG XINAN CHEMICAL INDUSTRIAL GROUP CO.,LTD	-1.69%	+0.20%	-3.79%	-14.30%	2B
LIER CHEMICAL CO.,LTD.	-2.57%	+7.99%	+14.04%	-2.23%	1.7B
ADAMA LTD.	+0.39%	+0.59%	-31.06%	-40.05%	1.7B
CAC NANTONG CHEMICAL CO., LTD.	-1.67%	-8.32%	-28.56%	-	1.47B
ANHUI GUANGXIN AGROCHEMICAL CO., LTD.	-1.16%	-0.87%	-14.72%	-46.03%	1.39B
SHENZHEN NOPOSION CROP SCIENCE CO., LTD.	+2.45%	+1.97%	-25.82%	+25.93%	1.25B
NANTONG JIANGSHAN AGROCHEMICAL & CHEMICALS CO.,LTD.	+2.37%	+9.79%	-15.10%	-22.28%	1.21B
LIMIN GROUP CO.,LTD.	+0.69%	+1.69%	-29.13%	+41.43%	914M
Average	-0.07%	+1.10%	-17.02%	-9.90%	1.66B
Weighted average by Cap.	-0.21%	+0.49%	-16.00%	-14.27%

	2026 *	2027 *
Net sales	5.1M 5.81M 4.75M 4.37M 8.19M 555M 8.33M 56.34M 22.05M 275M 21.82M 21.35M 951M	15.55M 17.72M 14.48M 13.32M 24.97M 1.69B 25.39M 172M 67.24M 840M 66.52M 65.08M 2.9B
Net income	-5.2M -5.93M -4.84M -4.45M -8.35M -566M -8.49M -57.45M -22.49M -281M -22.24M -21.76M -970M	550K 627K 512K 471K 883K 59.87M 898K 6.08M 2.38M 29.69M 2.35M 2.3M 103M
Net Debt	11.15M 12.71M 10.38M 9.55M 17.9M 1.21B 18.21M 123M 48.21M 602M 47.7M 46.67M 2.08B	11.85M 13.5M 11.03M 10.15M 19.03M 1.29B 19.35M 131M 51.24M 640M 50.69M 49.6M 2.21B

Amoéba Stock Euronext Paris

Stocks

Agricultural Chemicals

Valuation: Amoéba

Latest news : Amoéba

Press Releases: Amoéba

News in other languages: Amoéba

Managers and Directors: Amoéba

Pesticide

Financials

Company Profile